IP Verse

Gedeon Richter competitive analysis

Explore patent oppositions filed by Gedeon Richter against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 22, 2026

Patent Number	Title	Applicant	Opposition Date
EP3762015	Methods Of Treating Crohn'S Disease With Anti-Il23 Specific Antibody	JANSSEN BIOTECH	Sep 22, 2026
EP3519049	Safe And Effective Method Of Treating Psoriasis With Anti-Il23 Specific Antibody	JANSSEN BIOTECH	Sep 1, 2026
EP3689365	Use Of Long-Acting Glp-1 Peptides	NOVO NORDISK	May 6, 2026
EP2508188	Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate	ASTRAZENECA	Feb 9, 2024
EP4019041	Toxicity Management For Anti-Tumor Activity Of Cars	THE CHILDRENS HOSPITAL OF PHILADELPHIA	Sep 28, 2023
EP2578231	Antitumor T Cell Response Enhancer	CHUGAI SEIYAKU KABUSHIKI KAISHA	Jul 25, 2023
EP3433276	Early Intervention Methods To Prevent Or Ameliorate Toxicity	SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RESEARCH INSTITUTE	Sep 20, 2022
EP3048984	Ovulation Determination	VIVOSENSMEDICAL	Apr 28, 2022
EP2872171	Toxicity Management For Anti-Tumor Activity Of Cars	THE CHILDRENS HOSPITAL OF PHILADELPHIA	Oct 6, 2021
EP2139494	Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate	ASTRAZENECA	Dec 11, 2020

Discover the latest PTAB cases involving Gedeon Richter, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Gedeon Richter with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 22, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
GEDEON RICHTER PHARMA	9	-	-	-
JANSSEN BIOTECH	15	35	1	6
THE CHILDRENS HOSPITAL OF PHILADELPHIA	-	22	-	-
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA	-	48	-	7